klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
W
Y
Z
Ö
Cairo, S
Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest
Epigenetic perturbation by BMI-1 inhibitors as a novel therapeutic approach for hepatoblastoma
Cameron, R
Targeting the unique barcode of MLL/AF4
Campe, J
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors
Camps, J
Contribution of aneuploidy to the initiation and progression of childhood B-cell acute lymphoblastic leukemia
Cantilena, S
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Carcaboso, A
An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma
Cario, G
Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy
Cathomen, T
A selection free ex vivo gene therapy approach to congenital neutropenia causing HAX1 mutations
Caye-Eude, A
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Cazzaniga, G
Unravelling the recombinome of IKZF1 deletions in B-ALL
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL
Charlotte, MN
Prevention of relapse in juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
Che, N
Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia
Chetty, VK
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
Cifarelli, LN
Deciphering the molecular mechanism of NUP98-KDM5A chromosomal translocation in pediatric non-DS-AMKL
Cinar, B
SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway
Closa, A
A single-cell expression atlas of human AML-LScs unravels the contribution of HIF pathway and its therapeutic potential
Coleman, D
Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens
Cremer, A
High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty
transposon vectors